3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
6
Neoplasm Metastasis
5
Neoplasms
4
Triple Negative Breast Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Rectal Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Ovarian Epithelial
2
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Melanoma
1
Lung Neoplasms
1
Lung Cancer - Malignant Pleural Mesothelioma
1
Liver Neoplasms
1
Leukemia
1
Hematologic Neoplasms
1
Hemangiosarcoma
1
Gastrointestinal Stromal Tumors
1
Interventions
Cyclophosphamide
344
Cytarabine
281
fludarabine phosphate
201
Methotrexate
185
Filgrastim
159
Busulfan
147
Etoposide
135
Peripheral Blood Stem Cell Transplantation
133
fludarabine
127
Rituximab
119
Radiotherapy
111
Vincristine
102
Cyclosporine
98
Daunorubicin
96
Antilymphocyte Serum
94
Dexamethasone
91
Tacrolimus
85
Mycophenolic Acid
85
Whole-Body Irradiation
80
Melphalan
79
Idarubicin
67
Mercaptopurine
66
Imatinib Mesylate
66
Granulocyte Colony-Stimulating Factor
65
Azacitidine
65
Methylprednisolone
59
Prednisone
58
Doxorubicin
58
Clofarabine
54
sargramostim
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Leukemia
×
STA 9090
×
Clear all
NCT01236144
2014-06-11
AML18 Pilot
Cardiff University
Phase 1/2
Completed
113 enrolled